SBIR/STTR Research Award

Common Evidence Model for Advanced PHarmacOvigilance REsearch (Cemaphore)

Award identifier 8f0ee9555d01bed0e70dbb090e6ff06426b62c3d5aabd982c3b9aab642f1b061Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LTS COMPUTING LLC
Proposal award date
2019-09-16
Contract end date
2020-09-15
UEI
HFRRJKY6GBX9
Solicitation number
PA18-574
Topic code
300

Research abstract

SincePV overproducts of adverse drug reactionsOne of the major challenges that drug safety experts face when conduction pharmacovigilancePVis the many disparate evidence sources they have to contend with when identifyingprioritizingand evaluating PV signalsFewer patients would experience serious harm from drug therapies if PV experts had access to user friendly tools to help them more efficiently searchretrieveevaluateand synthesize drug safety evidence across all relevant sourcesIt is currently very difficult for experts to accurately synthesize evidence across multiple sources because each source has nonintuitive strengths and limitationsuses differing terminologiesand is available in different data formatsThe goal of this Phase I SBIR project is to develop the first pharmacovigilance signal generationprioritizationand validation platform to integrate the major pharmacovigilance evidence sources into a user friendly application based on scalable cloud based web servicesThe project team will use a systematic scientific approach to build a new working prototype for a commercial drug safety research platform called the Common Evidence Model for Advanced PHarmacOvigilance REsearchCemaphoreAimEvaluate a novel automated PV signal prioritization procedure across all the evidence sources in CemaphoreWe will develop and validate three novel algorithms thattogetherutilize the growing number of evidence sources within the Cemaphore to assess PV signal strengthnoveltyand public health impactAimTest the effect on PV signal prioritization of including evidence from predication based semantic indexingPSIof Structured Product LabelingPrior work has focused on PSI of only the indexed scientific literaturei eMEDLINEWe will generate semantic predications using SPLs for all prescription drugsintegrate this novel source into Cemaphoreand then test if the novel source improves PV signal generationAimConduct formative usability testing of a working prototype web UI for PV signal prioritization and validation built with web servicesWe will develop a Cemaphore web UI that provides a single unified view across harmonized evidence sources and publish web services to encourage integration and innovation in the wider eco system of safety PV applicationsThe services will provide a secureperformantcloud hostedREST API to access Cemaphore generated PV signals for hypothesis generationprioritized PV evidence metricsand positive negative controls for empirical calibration of observational study estimatesWe will engage PV experts in think aloud tests of a functional user interface that integrates these services into PV signal investigation workflowsThis SBIR Phase I project will demonstrate the technical merit and feasibility of Cemaphore for advancing active post market risk identification and analysisThe project will contribute to public health by greatly lowering the significant barriers that drug safety professionals face when investigating medication safety signals The goal of this Phase I SBIR project is to develop the first pharmacovigilance signal generationprioritizationand validation platform to integrate the major pharmacovigilance evidence sources into a user friendly application based on scalable cloud based web servicesThe project team will use a systematic scientific approach to build a new working prototype for a commercial drug safety research platform called the Common Evidence Model for Advanced PHarmacOvigilance REsearchCemaphoreThe project will contribute to public health by greatly lowering the significant barriers that drug safety professionals face when investigating medication safety signals

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.